Literature DB >> 2494991

Clavulanate inactivation of Staphylococcus aureus beta-lactamase.

I Rizwi1, A K Tan, A L Fink, R Virden.   

Abstract

The interaction of clavulanic acid with beta-lactamase from Staphylococcus aureus was investigated, particularly with a view to determining whether conformational effects are involved. The inactivation at neutral pH is essentially stoichiometric, leading to an inactive species with an enamine chromophore. Two forms of the enamine were observed, the first-formed having a positive ellipticity with a maximum near 290 nm. This species slowly converted into the stable form of the inactivated enzyme that had a negative ellipticity with a minimum at 275 nm. This change in sign of the ellipticity of the enamine is consistent with the previously proposed cis-trans isomerization of the enamine [Cartwright & Coulson (1979) Nature (London) 278, 360-361). Both the far-u.v.c.d. and the intrinsic viscosity of the inactivated enzyme indicated that negligible change in conformation of the enzyme accompanied inactivation. The rates of inactivation and enamine formation were compared at low temperatures, where the initial rates were slow enough to be monitored. The rate of loss of 95% of the catalytic activity was almost 100-fold faster than the rate of formation of the first-formed enamine species. The remaining 5% activity was lost with a rate comparable with that for formation of the initial enamine. The simplest explanation of these results is that a relatively stable acyl-enzyme intermediate builds up initially and more slowly partitions between turnover (hydrolysis) and enamine formation. The initially formed enamine is in the cis conformation but slowly isomerizes to the more stable trans form.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2494991      PMCID: PMC1138342          DOI: 10.1042/bj2580205

Source DB:  PubMed          Journal:  Biochem J        ISSN: 0264-6021            Impact factor:   3.857


  15 in total

1.  A semi-synthetic penicillinase inactivator.

Authors:  S J Cartwright; A F Coulson
Journal:  Nature       Date:  1979-03-22       Impact factor: 49.962

2.  The analysis of enzyme progress curves by numerical differentiation, including competitive product inhibition and enzyme reactivation.

Authors:  S C Koerber; A L Fink
Journal:  Anal Biochem       Date:  1987-08-15       Impact factor: 3.365

3.  A direct spectrophotometric assay and determination of Michaelis constants for the beta-lactamase reaction.

Authors:  A Samuni
Journal:  Anal Biochem       Date:  1975-01       Impact factor: 3.365

4.  Unfolding and refolding of Staphylococcus aureus penicillinase by urea-gradient electrophoresis.

Authors:  T E Creighton; R H Pain
Journal:  J Mol Biol       Date:  1980-03-15       Impact factor: 5.469

5.  Conformation of a stable intermediate on the folding pathway of Staphylococcus aureus penicillinase.

Authors:  E A Carrey; R H Pain
Journal:  Biochim Biophys Acta       Date:  1978-03-28

6.  A nonlinear regression program for small computers.

Authors:  R G Duggleby
Journal:  Anal Biochem       Date:  1981-01-01       Impact factor: 3.365

7.  The inhibition of staphylococcal beta-lactamase by clavulanic acid.

Authors:  C Reading; P Hepburn
Journal:  Biochem J       Date:  1979-04-01       Impact factor: 3.857

8.  Kinetic studies on the inactivation of Escherichia coli RTEM beta-lactamase by clavulanic acid.

Authors:  J Fisher; R L Charnas; J R Knowles
Journal:  Biochemistry       Date:  1978-05-30       Impact factor: 3.162

9.  Chemical studies on the inactivation of Escherichia coli RTEM beta-lactamase by clavulanic acid.

Authors:  R L Charnas; J Fisher; J R Knowles
Journal:  Biochemistry       Date:  1978-05-30       Impact factor: 3.162

10.  Penicillanic acid sulfone: interaction with RTEM beta-lactamase from Escherichia coli at different pH values.

Authors:  C Kemal; J R Knowles
Journal:  Biochemistry       Date:  1981-06-23       Impact factor: 3.162

View more
  8 in total

1.  Identification of products of inhibition of GES-2 beta-lactamase by tazobactam by x-ray crystallography and spectrometry.

Authors:  Hilary Frase; Clyde A Smith; Marta Toth; Matthew M Champion; Shahriar Mobashery; Sergei B Vakulenko
Journal:  J Biol Chem       Date:  2011-02-22       Impact factor: 5.157

2.  Importance of position 170 in the inhibition of GES-type β-lactamases by clavulanic acid.

Authors:  Hilary Frase; Marta Toth; Matthew M Champion; Nuno T Antunes; Sergei B Vakulenko
Journal:  Antimicrob Agents Chemother       Date:  2011-01-10       Impact factor: 5.191

3.  Amoxicillin-clavulanate therapy increases childhood nasal colonization by methicillin-susceptible Staphylococcus aureus strains producing high levels of penicillinase.

Authors:  Didier Guillemot; Stephane Bonacorsi; John S Blanchard; Philippe Weber; Sylvie Simon; Bruno Guesnon; Edouard Bingen; Claude Carbon
Journal:  Antimicrob Agents Chemother       Date:  2004-12       Impact factor: 5.191

Review 4.  Three decades of the class A beta-lactamase acyl-enzyme.

Authors:  Jed F Fisher; Shahriar Mobashery
Journal:  Curr Protein Pept Sci       Date:  2009-10       Impact factor: 3.272

5.  Why the extended-spectrum beta-lactamases SHV-2 and SHV-5 are "hypersusceptible" to mechanism-based inhibitors.

Authors:  Matthew Kalp; Christopher R Bethel; Robert A Bonomo; Paul R Carey
Journal:  Biochemistry       Date:  2009-10-20       Impact factor: 3.162

Review 6.  Three decades of beta-lactamase inhibitors.

Authors:  Sarah M Drawz; Robert A Bonomo
Journal:  Clin Microbiol Rev       Date:  2010-01       Impact factor: 26.132

7.  Kinetic and physical studies of beta-lactamase inhibition by a novel penem, BRL 42715.

Authors:  T H Farmer; J W Page; D J Payne; D J Knowles
Journal:  Biochem J       Date:  1994-11-01       Impact factor: 3.857

8.  Interactions between active-site-serine beta-lactamases and mechanism-based inactivators: a kinetic study and an overview.

Authors:  A Matagne; M F Ghuysen; J M Frère
Journal:  Biochem J       Date:  1993-11-01       Impact factor: 3.857

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.